1. The hepatic metabolism of hypoxanthine was investigated by studying both the fate of labelled hypoxanthine, added at micromolar concentrations to isolated rat hepatocyte suspensions, and the kinetic properties of purified hypoxanthine/guanine phosphoribosyltransferase from rat liver. 2. More than 80% of hypoxanthine was oxidized towards allantoin; less than 5% of the label was incorporated into the purine mononucleotides, and a similar proportion appeared transiently in inosine. The maximal velocity of oxidation (approx. 750nmol/min per g of cells) was in close agreement with the known activity of xanthine oxidase in liver extracts. In contrast, the maximal velocity of the incorporation of labelled hypoxanthine into mononucleotides reached only 30nmol/min per g of cells, compared with an activity of hypoxanthine/guanine phosphoribosyltransferase, measured at substrate concentrations analogous to those prevailing intracellularly, of 500nmol/min per g of cells. 3. Hypoxanthine incorporation into the mononucleotides was decreased by allopurinol, anoxia and ethanol, despite inhibition of its oxidation under these conditions; it was increased by incubation of the cells in supraphysiological concentrations of Pi.
Allopurinol and anoxia decreased the concentration of phosphoribosyl pyrophosphate inside the cells by respectively 40 and 60%, ethanol had no effect on the concentration of this metabolite and Pi increased its concentration up to 10-fold. 4. The kinetic study of purified hypoxanthine/guanine phosphoribosyltransferase showed that a mixture of ATP, IMP, GMP and GTP, at the concentrations prevailing in the liver cell, decreased the Vmax. of the enzyme 6-fold, increased its Km for hypoxanthine from 1 to 4pM and its Km for phosphoribosyl pyrophosphate from 2.5 to 25 pM. In the presence of 5upM-hypoxanthine and 2.5ypM-phosphoribosyl pyrophosphate, the mixture of nucleotides inhibited the activity of purified hypoxanthine/guanine phosphoribosyltransferase by 95%. 5. It is concluded that this inhibition results in a limited participation of hypoxanthine/guanine phosphoribosyltransferase in the control of the production of allantoin by the liver.
Investigations of the uptake of supraphysiological concentrations of hypoxanthine (100-200,uM) by isolated rat hepatocytes have shown that only small amounts were incorporated into the cellular nucleotide pool (Smith et al., 1977; Lalanne & Lafleur, 1980) . The reasons for this are not immediately apparent, since the Km for hypoxanthine as well as the Vmax. of HGPRT, the PPRibP (Clifford et al., 1972; Lalanne & Henderson, 1974 , 1975 and the Km of liver HGPRT for this metabolite (Olsen & Milman, 1974; Wohlhueter, 1975) are both around 5pM. In the present work, the reasons for the restricted incorporation of hypoxanthine in the hepatic purine mononucleotides have been investigated. This has been done by studying, under various experimental conditions, the fate of the purine base, added at micromolar concentrations, to isolated rat hepatocyte suspensions, and by assessing the kinetic properties of purified HGPRT from rat liver at concentrations of substrates and effectors analogous to those prevailing inside the cells.
Materials and methods Chemicals and enzymes
6-Mercapto-9-(tetrahydro-2-furyl)purine was a gift from Dr. Ven L. Narayanan, National Cancer Institute, Silver Spring, MD, U.S.A. Allopurinol [4-hydroxypyrazolo(3,4-d) pyrimidine], AMP-and GMP-agarose were obtained from Sigma Chemical Co., St. Louis, MO, U.S.A. DEAE-cellulose (DE 52) was from Whatman Biochemicals, Maidstone, Kent, U.K. Sephadex G-25 (fine grade) and Sephacryl S-300 were from Pharmacia Fine Chemicals, Uppsala, Sweden. APRT was purified from liver by affinity chromatography on AMPagarose (Hershey & Taylor, 1978) , to a specific activity of 0.2unit/mg of protein at 37°C. The enzyme was stored in 0.3% bovine serum albumin. Immediately before use, in order to remove PPRibP, it was filtered by centrifugation, as described by Penefsky (1977) , through a column (0.4cm x 6cm) containing Sephadex G-25 (fine grade) equilibrated with 50mM-Tris/HCl buffer (pH 7.4)/l0mM-MgSO4/30mM-KCl. GTP and PPRibP (tetrasodium salt) were from Boehringer GmbH, Mannheim, Germany. GTP was purified immediately before use by DEAE-cellulose chromatography, with a 0-0.5M linear gradient of NaCl in 20mM-Tris/HCl buffer, pH 7.0. It was free of GMP and contained less than 2% of GDP as checked by high-pressure anion-exchange chromatography. PPRibP was found to be 25-30% pure by the assay described below. [8-'4C]Hypoxanthine (53 Ci/mol), [8-' 4C] inosine (55 Ci/mol), [8-'4C] IMP (56Ci/mol) and [U-'4C]adenine (296 Ci/mol) were purchased from The Radiochemical Centre, Amersham, Bucks., U.K. For the assay of PPRibP, it was purified on polyethyleneimine-Acellulose thin-layer plates that were developed in butan-l-ol/methanol/water (1 :1 :8, by vol.) ('Reibel & Rovetto, 1978 (Crabtree & Henderson, 1971 ). One-dimensional chromatography of the purine mononucleotides on polyethyleneiminecellulose thin-layer plates (Crabtree & Henderson, 1971) was hampered by the presence of labelled uric acid, which trailed over the plates. In some experiments, determination of the radioactivity in the individual nucleotides was therefore performed by separating first the nucleosides and bases from the nucleotides on cellulose plates. Thereafter the nucleotide spot (remaining at the origin), was scraped off, the powder was eluted with water, and the concentrated eluate was applied on the polyethyleneimine-cellulose thin-layer plate. The concentration of hypoxanthine, measured spectrophotometrically by the method of Jorgensen (1974) 
Purification ofhypoxanthine/guaninephosphoribosyltransferase
All steps were carried out at 0-4°C. Rat liver (8-lOg) was homogenized in 2vol. of 50mM-Tris/HCl buffer, pH7.4, containing 50mM-KCl, 6mM-MgCl2, 0.1 mM-EDTA and 2mM-dithiothreitol (buffer A). After centrifugation for 60min at 30000g, the supernatant was heated for 3min at 70°C. After cooling, it was centrifuged for 10min at 14000g and the resulting supernatant was applied on a Sephacryl S-300 column (2.6cm x 35cm) equilibrated with buffer A. The column was eluted with the same buffer. Fractions (2ml) containing maximal enzyme activity (accounting together for approx. 5% of total proteins) were applied on a GMP-agarose column (0.7cm x 6cm) equilibrated with 20mM-Tris/HCl buffer, pH7.4, containing 20mM-KCl, 6mM-MgCl2, 0.1 mM-EDTA and 2mM-dithiothreitol (buffer B). After washing with lOml of buffer B, elution of HGPRT was performed by adding 0.25mM-PPRibP in the same buffer. The enzyme was purified 800-1 300-fold (to a specific activity of 12-19 units/mg of protein) and was free of adenine phosphoribosyltransferase, xanthine oxidase, nucleoside phosphorylase and 5'-nucleotidase activity. It was stored at 0°C in 0.2% bovine serum albumin. Immediately before use, the enzyme was filtered by centrifugation on a column (0.4cm x 6cm) containing Sephadex G-25 (fine grade) in buffer A, as described by Penefsky (1977) , to remove PPRibP.
Results

Rates of metabolism of hypoxanthine in isolated hepatocytes
Addition of labelled hypoxanthine, at micromolar concentrations, resulted in its rapid uptake and metabolism. As shown in Fig. 1 , lOM-hypoxanthine was nearly completely metabolized within 60s, 80% being oxidized towards allantoin and 4% incorporated into the mononucleotides; further analysis of this fraction showed that 1.3% of the label was incorporated in IMP, 0.1% in AMP, 0.8% in ADP and 1.8% in ATP. Approx. 4% of the label appeared in inosine at lOs and disappeared progressively thereafter. The curves ( Effects of the inhibition of xanthine oxidase
In view of the very rapid oxidation of hypoxanthine, experiments were designed to inhibit this process. Allopurinol, a potent inhibitor of xanthine oxidase, renders hypoxanthine instead of allantoin the final product of adenine nucleotide catabolism. Accordingly, lO0M-allopurinol caused a nearly complete block of the oxidation of hypoxanthine into allantoin (Fig. 3b) . Contrary to expectations, the initial rate of incorporation of hypoxanthine into the purine nucleotides was diminished from 14 to 8 nmol/min per g of cells (Fig. 3d) . The utilization of hypoxanthine was profoundly decreased (Fig. 3a) , and a progressive accumulation of the label in inosine became evident (Fig. 3c) . The rate of incorporation of hypoxanthine decreased rapidly after lOs. In the control hepatocytes, as shown in Fig. 1 , it stopped when the purine base was completely utilized. In the presence of allopurinol it continued over the whole 60min duration of the experiment, at a rate of 1 .5nmol/min per g of cells (Fig. 3d, inset) , owing to the persistence of the purine base in the cell suspension.
Substantial evidence has been presented that xanthine oxidase acts as a NADI-dependent dehydrogenase in vivo (Battelli et al., 1972; Waud & Rajagopalan, 1976) . Increases in the NADH/ NADI ratio, such as those induced by anoxia or ethanol, might thus be expected to modify the metabolism of hypoxanthine. As shown in Fig. 4 , preincubation of isolated hepatocytes with ethanol or in a N2/CO2 atmosphere induced only slight decreases in the rate of utilization of lOpM-hypoxanthine ( Fig. 4a) and in the formation of its oxidation products (Fig. 4b ). More pronounced effects, which were most marked in anoxic conditions, were observed on the transient conversion into inosine, which was enhanced (Fig. 4c) , and on the incorporation into the nucleotides, which was decreased (Fig. 4d ). All these effects were accentuated with higher concentrations of hypoxanthine (results not shown).
The decrease in the rate of incorporation of hypoxanthine into the nucleotides, observed with the various inhibitors of xanthine oxidase, prompted a study of their influence on the concentration of PPRibP, the other substrate of HGPRT. Depending on the batch of hepatocytes, the concentration of PPRibP varied from 2 to 6nmol/g of cells. The concentration of PPRibP was decreased by approx. 40% after 5min of incubation with 100MuM-allopurinol, in accordance with data reported for erythrocytes by Fox et al. (1970) . It decreased by 60% after 20min of gassing with N2/CO2, but was not significantly modified 15 min after the addition of 20mM-ethanol.
Influence of high concentrations of Pi
The observation that two of the experimental conditions that decreased the rate of incorporation of hypoxanthine into the purine nucleotides, namely incubation with allopurinol and in N2/CO2, also decreased the concentration of PPRibP, prompted a study of the influence of increasing this substrate on the metabolism of hypoxanthine. The concentration of PPRibP can be increased in various types of cells by their incubation with supraphysiological concentrations of Pi (Hershko et al., 1967; Barankiewicz & Henderson, 1977; Bashkin & Sperling, 1978; Raivio et al., 1981) . In accordance with those studies, we found that the intracellular concentration of PPRibP in isolated hepatocytes increased in a concentration-dependent way on addition of Pi. As depicted in Fig. 5(b) , these conditions also provoked a concentration-dependent enhancement of the incorporation of hypo- xanthine into the purine nucleotides, up to about 3-fold the control value at 25mM-Pi In contrast, the transient accumulation of inosine recorded after the addition of hypoxanthine was decreased by more than 50% (Fig. 5a) . The rates of utilization of hypoxanthine and of its conversion into allantoin were not significantly modified (results not shown). The effect of 25 mM-Pi to increase the concentration of PPRibP and the rate of incorporation of hypoxanthine into the nucleotides was also observed in the presence of allopurinol. It resulted in a complete conversion of the purine base into nucleotides within 15min (results not shown).
Effects of the inhibition of HGPRT
As an additional assessment of the role of HGPRT in the metabolism of hypoxanthine, either added to the hepatocyte suspension or generated during normal purine catabolism, experiments were performed with 6-mercapto-9-(tetrahydro-2-furyl)purine, an inhibitor of this Vol. 222 enzyme in human erythrocytes and mouse ascitestumour cells (Jadhav et al., 1979) . It was verified that this compound also inhibited purified HGPRT from rat liver (see below). The incorporation of 20pM-hypoxanthine into nucleotides was decreased in a dose-dependent manner, to 40% of the control value at 0.5-1 mm inhibitor, without significant modification of the concentration of PPRibP (results not shown). 6-Mercapto-9-(tetrahydro-2-furyl)purine also induced a small dosedependent decrease in the utilization of hypoxanthine and a parallel increase in the accumulation of inosine (results not shown The concentrations of the effectors used are those present in control liver (Clifford et al., 1972; Vincent et al., 1982 Studies with purified HGPRT Fig. 6(a) (Fig. 6b) . The order of potency of physiological concentrations of the inhibitory nucleotides and their effect on the Vmax. were comparable with those depicted in Fig. 6(a) . Their influence was, however, more pronounced on the Km for PPRibP than on the affinity for hypoxanthine. The physiological mixture of nucleotides increased the Km of the enzyme for PPRibP approx. 10-fold. Measurements of the activity of purified HGPRT at concentrations of hypoxanthine and PPRibP in the physiological range (5 and 2.5 uM respectively) revealed that it was 95% inhibited by the physiological mixture of nucleotides. The same degree of inhibition was observed in the presence of mixtures of nucleotides at concentrations prevailing in the liver cells in anoxia (Vincent et al., 1982) (results not shown). Other nucleotides, namely ADP and AMP, as well as Pi and PPi, were without effect when added at physiological concentrations. The activity of purified HGPRT was inhibited by 70% by 0.5mM-6-mercapto-9-(tetrahydro-2-furyl)purine and was not influenced by glycerol 3-phosphate up to 10mM.
Discussion
In the liver cell, hypoxanthine is formed from inosine by nucleoside phosphorylase and can be either reutilized by HGPRT to form IMP, or oxidized to the terminal product of hepatic purine catabolism, uric acid or allantoin according to the species (Scheme 1). In addition, the possibility exists that HGPRT, together with the cytoplasmic 5'-nucleotidase and nucleoside phosphorylase, may allow a futile recycling of metabolites, as shown by Barankiewicz et al. (1982) distally from AMP deaminase, the limiting enzyme of this process (for a review see Van den Berghe, 1981) . It could also potentially play a role in the regulation of the purine economy of the body as a whole, since it may control the fate of hypoxanthine, provided to the liver by tissues in which the latter compound constitutes the end-product of purine catabolism. Finally, the sum of the activities of HGPRT and xanthine oxidase may determine the supply of purines, in the form of hypoxanthine, to other organs. Indeed, the liver is often considered the major source of purine available to other tissues for salvage (for a review see Murray, 1971) . In the present work, information about the three routes of hypoxanthine metabolism has been obtained by combining studies of the fate of labelled hypoxanthine added to suspensions of isolated rat hepatocytes with a kinetic investigation of purified HGPRT from rat liver.
Oxidation of hypoxanthine
In accordance with findings by other authors (Smith et al., 1977; Lalanne & Lafleur, 1980) , we found that hypoxanthine added to suspensions of isolated rat hepatocytes was rapidly metabolized, mainly to allantoin (Fig. 1) . The maximal velocity of this process reaching 750nmol/min per g of cells (Fig. 2) , is in close agreement with the Vmax. of xanthine oxidase, determined in rat liver extracts (Stirpe & Della Corte, 1969; Hashimoto, 1974 ).
The concentration of hypoxanthine providing the half-maximal rate of oxidation (20uM) was about 10-fold higher than the Km for xanthine of the purified rat liver enzyme (Waud & Rajagopalan, 1976) . The nearly complete inhibition of the oxidation of hypoxanthine towards allantoin, observed in isolated hepatocytes in the presence of allopurinol (Fig. 3b) , is in agreement with the findings of Lalanne & Lafleur (1980) . The decrease in the rate of oxidation of hypoxanthine in the presence of ethanol and in anoxia (Fig. 4b) , and its dependence on the concentration of the purine base (M. F. Vincent, unpublished work), can be explained by an inhibition of the dehydrogenase (type D) form of xanthine oxidase by NADH, as shown in rat liver extracts by Della Corte & Stirpe (1970) and with the partially purified enzyme by Kaminski & Jezewska (1981) . It is indeed postulated that xanthine oxidase is predominantly in the dehydrogenase form intracellularly, as also evidenced by our previous finding (Vincent et al., 1982) that anoxic hepatocytes continue to form uric acid, although, in accordance with the oxygendependence of urate oxidase (Keilin & Hartree, 1936) , their production of allantoin is inhibited. In comparison with the marked elevation of the NADH/NAD+ ratio recorded under the influence of ethanol and anoxia, and with the low Ki (about 3 gM) of the inhibition of xanthine dehydrogenase by NADH (Della Corte & Stirpe, 1970) , the decrease in the metabolism of hypoxanthine nevertheless appears strikingly limited. This may be explained by the existence of multiple cytoplasmic pools of NAD+, which are influenced to different degrees by modifications of the redox state of the hepatocyte, as demonstrated by Berry et al. (1980) .
Conversion of hypoxanthine into inosine
The transient increase in the concentration of inosine, observed after the addition of lOuMhypoxanthine to the hepatocyte suspension (Figs. 1, 3c, 4c and 5a), has also been observed with higher concentrations of the purine base by Lalanne & Lafleur (1980) . As discussed by those authors, it could be explained by a reversal of the nucleoside phosphorylase reaction or/and by the hydrolysis of IMP formed from hypoxanthine. This hydrolysis involves the cytoplasmic 5'-nucleotidase, which, according to our previous studies (Van den Berghe et al., 1977b; Bontemps et al., 1983) , is the only 5'-nucleotidase that intervenes in the catabolism of intracellular hepatic 5'-nucleotides. From the observation that the accumulation of inosine was decreased when the hepatocytes were incubated in supraphysiological concentrations of Pi (Fig. 5a ), Lalanne & Lafleur (1980) had concluded that it resulted from the ribosylation of hypoxanthine. Indeed, the Km for Pi of nucleoside phosphorylase reaches approx. 15 mM (Lewis & Glantz, 1976 inhibition of HGPRT by 6-mercapto-9-(tetrahydro-2-furyl)purine increased rather than decreased the accumulation of inosine recorded after the addition of hypoxanthine. Secondly, the accumulation of inosine was greatly enhanced by both allopurinol (Fig. 3c) and anoxia (Fig. 4c) (Vincent et al., 1982) .
Phosphoribosylation of hypoxanthine
The discrepancy between the high activity of HGPRT in hepatocyte extracts and the low rate of incorporation of hypoxanthine in intact cells has also been noted by Smith et al. (1977) . It is also found in mouse brain (Wong & Henderson, 1972) , human leucocytes , Ehrlich ascites-tumour cells , erythrocytes of several mammalian species (Lalanne & Willemot, 1980) and rat hepatoma cells (Wohlhueter et al., 1982) . Its explanation requires an evaluation of the kinetic properties of HGPRT in the conditions prevailing inside the cells. By allowing a quantitative estimate of hypoxanthine salvage, our results also provide an insight into the physiological significance of this process in the liver.
Kinetic properties of HGPRT. Inhibition of HGPRT from different tissues by several mononucleotides, including IMP and GMP, products of the reaction, has been reported (Murray, 1966; Krenitsky & Papaioannou, 1969; Olsen & Milman, 1974) . Its physiological significance had, however, not been evaluated. Our results show that a mixture of inhibitory nucleotides, at the concentrations prevailing in the liver cell, markedly affects some of the kinetic parameters of the enzymic reaction. In particular, the Vmax. of the enzyme is profoundly decreased, its Km for hypoxanthine being elevated about 4-fold and its Km for PPRibP increased approx. 10-fold. The 95% decrease, by the mixture of inhibitory nucleotides, of the reaction rate of the purified enzyme, measured at concentrations of hypoxanthine and PPRibP in the physiological range is in close agreement with the limited incorporation of hypoxanthine into the nucleotides of the intact cells. Whereas the Km for hypoxanthine of purified HGPRT (Fig. 6a) was also in good agreement with the concentration of the purine base providing its half-maximal rate of incorporation into the cellular purine nucleotides, namely 2pM (Fig. 2) , we have no explanation as yet for the decrease in the latter process observed at hypoxanthine concentrations above 25tM. The inhibition of HGPRT by an excess of substrate which we have found in crude liver extracts confirms data for the same preparation by Wohlhueter (1975) . It has, however, not been reported for the purified enzyme. An increased feedback inhibition, caused by an elevation of the concentration of IMP, appears unlikely in view of the limited incorporation of hypoxanthine into the nucleotides.
The mixture of inhibitory nucleotides increased the Km for PPRibP of purified liver HGPRT from approx. 2.5 pM, which is in the range of the hepatic concentration of this metabolite, to about 25 pm.
The decrease in the velocity of the incorporation of hypoxanthine into the nucleotides induced by allopurinol and anoxia, as well as its increase in the presence of supraphysiological concentrations of Pi, can thus be explained by the modification of the concentration of PPRibP recorded in these conditions. The slower but long-lasting incorporation of hypoxanthine into the nucleotides recorded in the presence of allopurinol (Fig. 3d) , is in accordance with the 10-fold augmentation of the incorporation of hypoxanthine into rat liver nucleic acid purines observed 17 h after the administration of allopurinol in vivo (Pomales et al., 1963) . We have no explanation as yet for the decreased incorporation of hypoxanthine into the nucleotides provoked by ethanol, since this compound did not modify the concentration of PPRibP. The activity of purified liver HGPRT was also not influenced by concentrations of glycerol 3-phosphate in the range of those recorded after ethanol administration (results not shown).
Physiological significance ofhypoxanthine salvage. Previous work from this laboratory has led to the conclusion that AMP deaminase constitutes the initial step as well as the limiting enzyme of the catabolism of the adenine nucleotides in the liver (Van den Berghe et al., 1977a Berghe et al., ,b, 1980 Vincent et al., 1982) . A continuous production of adenosine by the cytoplasmic 5'-nucleotidase, discovered by Bontemps et al. (1983) , was shown not to contribute to the basal production of allantoin because of the recycling of adenosine by adenosine kinase. Our present work was aimed at an evaluation of the role of HGPRT in the control of the hepatic production of allantoin from hypoxanthine derived from this organ or from other tissues.
In theory, the exact rate of reutilization of hypoxanthine by the liver in physiological conditions, as well as the existence of a futile cycle between IMP and hypoxanthine, could be assessed by the increase in the turnover rate of the adenine nucleotides and of the production of allantoin induced by a complete inhibition of the activity of HGPRT. However, because of the low potency of the HGPRT inhibitor 6-mercapto-9-(tetrahydro-2-furyl)purine, no conclusion could be drawn from the observation that neither parameter was modified by the addition of this compound. From the data depicted in Fig. 2 , it can be calculated that at concentrations of hypoxanthine around that observed in rat liver (below 1 gM in basal conditions) the rate of reutilization of the purine base is proportional to its concentration and reaches 20-30% of its rate of oxidation. Increases in the concentration of hypoxanthine, such as recorded in human plasma during intense exercise (Harkness et al., 1983) , will thus result not only in an increase in the rate of oxidation of the purine base, but also in an enhancement of its rate of reutilization, thereby limiting to a certain extent the loss of purines known to occur under these conditions (Sutton et al., 1980) . In so far as they can be extrapolated to human pathology, our results indicate that the liver contributes little to the overproduction of uric acid caused by the deficiency of HGPRT, characterizing the Lesch-Nyhan syndrome (Seegmiller et al., 1967) , as well as by other kinetic abnormalities of the enzyme (for a review see Wilson et al., 1983) .
